Researchers from Imperial College London and Imperial College Healthcare NHS Trust have developed an artificial intelligence (AI) powered stethoscope capable of detecting three significant heart conditions—heart failure, heart valve disease, and abnormal heart rhythms—within seconds. This innovation seeks to enhance early diagnosis and treatment for patients, which could potentially change the landscape of cardiac care.
Historically, the stethoscope, invented in 1816, has enabled healthcare professionals to listen to internal bodily sounds. The new AI-driven device, however, replaces the traditional chest piece with a compact unit resembling a playing card. It utilizes a microphone to identify subtle variations in heartbeat and blood flow, which human ears may miss. Additionally, it records electrocardiogram (ECG) data, transmitting this information to the cloud for analysis by AI algorithms trained on extensive patient data.
The study, which involved over 12,000 patients across 205 GP surgeries in London, revealed that patients examined with the AI stethoscope were 2.33 times more likely to receive a heart failure diagnosis within a year. Moreover, abnormal heartbeat patterns, which can elevate stroke risk, were identified 3.5 times more frequently with the AI technology, while heart valve disease detection increased by 1.9 times.
Dr. Sonya Babu-Narayan, clinical director at the British Heart Foundation, emphasized the importance of such advancements, noting that early diagnosis can lead to timely treatment and improved patient outcomes. The findings from this research have been presented at the European Society of Cardiology annual congress in Madrid, with plans underway to deploy these AI stethoscopes in various regions across the UK, including south London, Sussex, and Wales.